donation
To request Mental Health
Services or to access Mental
Health Crisis Services Call:
1-800-375-4357

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Biden Administration Withdraws Vaccine Mandate for Large EmployersFree N95 Masks Begin Arriving in U.S. PharmaciesEngland to Lift Travel Restrictions for Vaccinated VisitorsMany Marijuana Vendors Aim Advertising at Kids: StudyConservatorships Keep the Homeless in Psychiatric Wards Too Long: StudyCrowded Emergency Rooms Cost Lives: StudyColonoscopy Surprise Bills Should Be Thing of the Past, Experts SayBiden Plans to Send 400 Million N95 Masks to Americans for FreeWhite House Launches Website for Free Home COVID Tests One Day Ahead of SchedulePolitics Clouds Folks' Views on COVID Rules, Global Survey ConfirmsCOVAX Program Has Now Sent 1 Billion COVID Vaccines to Poorer NationsAmid U.S. Blood Shortage, New Pressure to Ease Donor Rules for Gay MenSupreme Court Blocks Biden's Vaccine Mandate for Large EmployersWhite House May Soon Offer 'High-Quality' Masks to AmericansAmericans Should Avoid Travel to Canada: CDCRed Cross Says U.S. Blood Supply at Dangerously Low Level'Secondhand Vaping' May Be Unhealthy — Could Public Bans Be Coming?Many Doctors Uninformed on Rights of Disabled PatientsAmid COVID Test Shortages, Price Gouging Is on the RiseSupreme Court Hears Arguments on Biden's Vaccine Mandate for Big BusinessMore Evidence That State Lotteries Didn't Boost Vaccination RatesWhite House Finalizes Plan to Send Americans Free COVID Rapid TestsMembers of Biden’s Transition Team Call for New COVID PlanDirty City Air Killed More Than 1.8 Million People Globally in 2019Telemedicine as Good as In-Person for Many Health Conditions: ReviewPrison Time Shortens Life Spans for Black Americans, But Not WhitesHeat Waves Bring Health Crises to the HomelessBiden Outlines Measures to Fight Omicron, Pleads With Americans to Get VaccinatedProctor & Gamble Recalls Pantene, Herbal Essences Products Due to BenzeneEarly CDC COVID Tests Were Not Only Contaminated, But Flawed: ReportMany Home Health Care Workers in Poor Health ThemselvesPoor Outcome More Likely When Patient Is Female, Surgeon Is Male: StudyMonths After New Rule, More Than Half of U.S. Hospitals Still Don't Disclose Prices OnlineReport Finds World Ill-Prepared for Next PandemicU.S. to Pump $400 Million Into Vaccination Programs for Other CountriesOver 234,000 Pounds of Ham, Pepperoni Recalled Due to ListeriaCOVID Vaccine, Testing Demand Overwhelming PharmaciesAlmost 13 Million Americans Per Year Skip Meds Due to CostAssistance Dogs Bring Big Boost to Deaf PeopleCDC to Toughen COVID Testing for International TravelersOld Spice, Secret Antiperspirants Recalled Due to BenzeneClinical Trials Are Becoming More Diverse, But There's Still Work To DoRural Hospitals' ERs Just as Effective as Urban Ones: StudyKraft Recalls Powdered Drinks Over Metal, Glass ConcernsVials Found in Lab Contained Vaccine, not Smallpox Virus: CDCAdvances in Care, Impact of COVID Highlights of Latest Cardiologists' MeetingAcross America, Black People Have Worse Health OutcomesVials With Smallpox Labels Found at Vaccine Lab in Pennsylvania: CDCWhite House to Spend Billions to Boost COVID Vaccine SupplyAHA News: Health Class May Influence Heart Risk in South Asians
Questions and AnswersLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Clinical Trials Are Becoming More Diverse, But There's Still Work To Do

HealthDay News
by Robert Preidt
Updated: Nov 30th 2021

new article illustration

TUESDAY, Nov. 30, 2021 (HealthDay News) -- U.S. cancer clinical trial participants have become more diverse in makeup, but certain groups remain underrepresented, a new study finds.

It's important to have a wide range of participants in clinical trials, to find out if treatments are safe and effective for people with different characteristics, according to the National Cancer Institute (NCI), which has a number of initiatives to boost diversity in clinical trials it funds.

"Our article indicates that the disparity for clinical enrollment in NCI clinical trials has narrowed for minorities, but further efforts are still needed," study author Dr. Juan Javier-DesLoges of UC San Diego Health said in a journal news release.

In this latest study, researchers analyzed 766 NCI-funded breast, colon, lung and prostate cancer trials conducted from 2000 to 2019. Of the nearly 243,000 people in the trials, 81.3% were white, 8.7% were Black, 4.8% were Hispanic and 2.8% were Asian/Pacific Islanders.

When the researchers compared clinical trial participation from 2015 to 2019 with cancer incidence rates from 2015 to 2017, they found that Blacks and Hispanics were more likely to participate in breast cancer clinical trials, but were underrepresented in colon, lung and prostate cancer trials.

People older than 65 were underrepresented in breast, colon and lung cancer trials, and women were underrepresented in colon and lung cancer trials.

When the researchers compared trial participation in 2000–2004 and 2015–2019, they found that Hispanics and Blacks were more likely to be included in recent breast, lung and prostate cancer trials.

While women were less likely to be included in recent colon cancer trials, they were more likely to take part in recent lung cancer trials.

Trends on the inclusion of patients 65 and older varied by cancer type, according to the study published online Nov. 22 in the journal Cancer.

Further work is needed to correct continuing underrepresentation of women and older patients in clinical trials, the researchers noted.

More information

The U.S. National Cancer Institute has more on clinical trials.


SOURCES: Cancer, news release, Nov. 22, 2021